These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38188856)

  • 1. Evaluating a smartphone-based symptom self-monitoring app for psychosis in China (YouXin): A non-randomised validity and feasibility study with a mixed-methods design.
    Zhang X; Lewis S; Carter LA; Chen X; Zhou J; Wang X; Bucci S
    Digit Health; 2024; 10():20552076231222097. PubMed ID: 38188856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Digital System (YouXin) to Facilitate Self-Management by People With Psychosis in China: Protocol for a Nonrandomized Validity and Feasibility Study With a Mixed Methods Design.
    Zhang X; Lewis S; Carter LA; Bucci S
    JMIR Res Protoc; 2023 Sep; 12():e45170. PubMed ID: 37698905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability and experience of a smartphone symptom monitoring app for people with psychosis in China (YouXin): a qualitative study.
    Zhang X; Lewis S; Chen X; Zhou J; Wang X; Bucci S
    BMC Psychiatry; 2024 Apr; 24(1):268. PubMed ID: 38594713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smartphone-Enhanced Symptom Management In Psychosis: Open, Randomized Controlled Trial.
    Lewis S; Ainsworth J; Sanders C; Stockton-Powdrell C; Machin M; Whelan P; Hopkins R; He Z; Applegate E; Drake R; Bamford C; Roberts C; Wykes T
    J Med Internet Res; 2020 Aug; 22(8):e17019. PubMed ID: 32788150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse: the EMPOWER feasibility cluster RCT.
    Gumley AI; Bradstreet S; Ainsworth J; Allan S; Alvarez-Jimenez M; Birchwood M; Briggs A; Bucci S; Cotton S; Engel L; French P; Lederman R; Lewis S; Machin M; MacLennan G; McLeod H; McMeekin N; Mihalopoulos C; Morton E; Norrie J; Reilly F; Schwannauer M; Singh SP; Sundram S; Thompson A; Williams C; Yung A; Aucott L; Farhall J; Gleeson J
    Health Technol Assess; 2022 May; 26(27):1-174. PubMed ID: 35639493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
    Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
    Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smartphone-delivered self-management for first-episode psychosis: the ARIES feasibility randomised controlled trial.
    Steare T; O'Hanlon P; Eskinazi M; Osborn D; Lloyd-Evans B; Jones R; Rostill H; Amani S; Johnson S
    BMJ Open; 2020 Aug; 10(8):e034927. PubMed ID: 32847902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smartphone digital phenotyping, surveys, and cognitive assessments for global mental health: Initial data and clinical correlations from an international first episode psychosis study.
    Lakhtakia T; Bondre A; Chand PK; Chaturvedi N; Choudhary S; Currey D; Dutt S; Khan A; Kumar M; Gupta S; Nagendra S; Reddy PV; Rozatkar A; Scheuer L; Sen Y; Shrivastava R; Singh R; Thirthalli J; Tugnawat DK; Bhan A; Naslund JA; Patel V; Keshavan M; Mehta UM; Torous J
    Digit Health; 2022; 8():20552076221133758. PubMed ID: 36386246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative study of stakeholder views on the use of a digital app for supported self-management in early intervention services for psychosis.
    Steare T; Giorgalli M; Free K; Harju-Seppänen J; Akther S; Eskinazi M; O'Hanlon P; Rostill H; Amani S; Lloyd-Evans B; Osborn D; Johnson S
    BMC Psychiatry; 2021 Jun; 21(1):311. PubMed ID: 34147075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using mobile technology to deliver a cognitive behaviour therapy-informed intervention in early psychosis (Actissist): study protocol for a randomised controlled trial.
    Bucci S; Barrowclough C; Ainsworth J; Morris R; Berry K; Machin M; Emsley R; Lewis S; Edge D; Buchan I; Haddock G
    Trials; 2015 Sep; 16():404. PubMed ID: 26357943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the Utility of Smartphone-Based Sensor Assessments in Persons With Multiple Sclerosis in the Real-World Using an App (elevateMS): Observational, Prospective Pilot Digital Health Study.
    Pratap A; Grant D; Vegesna A; Tummalacherla M; Cohan S; Deshpande C; Mangravite L; Omberg L
    JMIR Mhealth Uhealth; 2020 Oct; 8(10):e22108. PubMed ID: 33107827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EMPOWER blended digital intervention for relapse prevention in schizophrenia: a feasibility cluster randomised controlled trial in Scotland and Australia.
    Gumley AI; Bradstreet S; Ainsworth J; Allan S; Alvarez-Jimenez M; Aucott L; Birchwood M; Briggs A; Bucci S; Cotton SM; Engel L; French P; Lederman R; Lewis S; Machin M; MacLennan G; McLeod H; McMeekin N; Mihalopoulos C; Morton E; Norrie J; Schwannauer M; Singh SP; Sundram S; Thompson A; Williams C; Yung AR; Farhall J; Gleeson J
    Lancet Psychiatry; 2022 Jun; 9(6):477-486. PubMed ID: 35569503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study.
    Morrison AP; Law H; Carter L; Sellers R; Emsley R; Pyle M; French P; Shiers D; Yung AR; Murphy EK; Holden N; Steele A; Bowe SE; Palmier-Claus J; Brooks V; Byrne R; Davies L; Haddad PM
    Lancet Psychiatry; 2018 May; 5(5):411-423. PubMed ID: 29605187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating a Smartphone App (MeT4VeT) to Support the Mental Health of UK Armed Forces Veterans: Feasibility Randomized Controlled Trial.
    Parkes S; Croak B; Brooks SK; Stevelink SAM; Leightley D; Fear NT; Rafferty L; Greenberg N
    JMIR Ment Health; 2023 Aug; 10():e46508. PubMed ID: 37639295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Long-Term Acceptability of ExPRESS, a Mobile Phone App to Monitor Basic Symptoms and Early Signs of Psychosis Relapse.
    Eisner E; Drake RJ; Berry N; Barrowclough C; Emsley R; Machin M; Bucci S
    JMIR Mhealth Uhealth; 2019 Mar; 7(3):e11568. PubMed ID: 30924789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of using a smartphone app to assess early signs, basic symptoms and psychotic symptoms over six months: A preliminary report.
    Eisner E; Bucci S; Berry N; Emsley R; Barrowclough C; Drake RJ
    Schizophr Res; 2019 Jun; 208():105-113. PubMed ID: 30979665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel smartphone-based intervention targeting sleep difficulties in individuals experiencing psychosis: A feasibility and acceptability evaluation.
    Taylor KM; Bradley J; Cella M
    Psychol Psychother; 2022 Sep; 95(3):717-737. PubMed ID: 35481697
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.